Monitor for any future amendments that show an increase above 5.16%, which could signal a more active stance, though Vanguard's passive filing makes that unlikely. No immediate catalyst from this routine disclosure.
Price Chart
Executive Summary
Vanguard Capital Management LLC disclosed a 5.16% passive stake in Palisade Bio, Inc. via a new Schedule 13G filing, holding 8,995,805 shares as of September 30, 2026. This is a new 5%+ disclosure by a major index fund manager, indicating routine passive investment rather than activist intent.
Key Financial Metrics
Key Facts
- Vanguard Capital Management LLC filed a new Schedule 13G disclosing beneficial ownership of 8,995,805 shares of Palisade Bio common stock.
- The stake represents 5.16% of shares outstanding as of September 30, 2026.
- The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
- Vanguard Capital Management is a large index fund manager; this is consistent with passive portfolio management.
- No prior 13G filing by Vanguard for Palisade Bio appears in the cross-filing context; this is a new position disclosure.
Financial Impact
Stake valued at approximately $10.7M based on $207M market cap and 5.16% ownership.
Risk Factors
- No activist intent is indicated; the filing is purely passive.
- The stake is modest at just over the 5% threshold, so no significant conviction signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002100119-26-001634 |
| Document: 0002100119-26-001634-index.html | 0002100119-26-001634 |
| Document: 0002100119-26-001634.txt | 0002100119-26-001634 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G | $1.17 | awaiting T+20 | awaiting T+20 | $1.16 (−0.43%) |
Sep 22, 2026 5w ago | Institutional Cluster | $1.69 $1.43 | ▼ −15.38% | ▼ −14.82% | $1.16 (−31.36%) |
Sep 22, 2026 5w ago | Press Release | $1.69 $1.43 | ▼ −15.38% | ▼ −14.82% | $1.16 (−31.36%) |
Aug 10, 2026 11w ago | 8-K | $2.14 $2.05 | ▼ −4.21% | ▼ −3.15% | $1.16 (−45.79%) |
Jul 10, 2026 16w ago | Insider Cluster | $1.89 $2.10 | ▲ +11.11% | ▲ +7.93% | $1.16 (−38.62%) |
Jul 8, 2026 16w ago | Insider Cluster | $1.97 $2.09 | ▲ +6.09% | ▲ +3.85% | $1.16 (−41.12%) |
Jun 11, 2026 20w ago | 8-K | $1.71 $1.96 | ▲ +14.62% | ▲ +12.84% | $1.16 (−32.16%) |
May 22, 2026 23w ago | EFFECT | $1.95 $1.89 | ▼ −3.08% | ▼ −1.66% | $1.16 (−40.51%) |
May 12, 2026 24w ago | S-3 | $1.87 $1.78 | ▼ −4.81% | ▼ −4.20% | $1.16 (−37.97%) |
Apr 29, 2026 26w ago | DEFA14A | $2.00 $2.12 | ▲ +6.00% | ▲ +0.77% | $1.16 (−42.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers